Incyte to Report Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 117.59 -2.45 (2.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.04 | 52 Week High | $118.49 | |||
| Open | $118.96 | 52 Week Low | $55.00 | |||
| Day High | $121.26 | P/E | N/A | |||
| Day Low | $117.27 | EPS | $-0.56 | |||
| Volume | 2,171,744 | |||||
